NCT01952288View on ClinicalTrials.gov

Simvastatin for mTBI

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 16, 2013

Primary Completion Date

June 20, 2017

Study Completion Date

June 20, 2017

Conditions
TBI-Traumatic Brain Injury
Interventions
DRUG

simvastatin

simvastatin 40 mg/day for 12 months

DRUG

Placebo Oral Tablet

placebo comparator

Trial Locations (1)

98108

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT01952288 - Simvastatin for mTBI | Biotech Hunter | Biotech Hunter